AXS vs FDS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AXS exhibits a weak Piotroski F-Score of 2/9, signaling significant financial health concerns, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company trades at a low P/E of 8.53 versus sector average of 20.94, shows strong recent earnings growth (YoY +83.3%), and beats estimates consistently, with a favorable analyst target of $120.91. However, deteriorating technical trend (0/100), bearish insider activity, and weak liquidity ratios (Current Ratio: 0.70, Quick Ratio: 0.19) counterbalance valuation appeal. The stock appears reasonably valued near $102 but faces structural balance sheet risks and negative insider sentiment.
FDS presents a stable but mediocre financial profile with a Piotroski F-Score of 4/9, indicating a lack of strong fundamental momentum. The stock is severely overvalued relative to its deterministic baselines, trading at $224.12 against a Graham Number of $142.49 and an Intrinsic Value of $108.71. While the company maintains high profitability (ROE 28.08%), it is currently plagued by negative earnings growth and a maximum bearish technical trend (0/100). The long-term price trajectory is deeply concerning, with a 1-year decline of 46.9%.
Compare Another Pair
Related Comparisons
AXS vs FDS: Head-to-Head Comparison
This page compares AXIS Capital Holdings Limited (AXS) and FactSet Research Systems Inc. (FDS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.